NCT07430982Completed
Evaluation of Endothelial Dysfunction in Geriatric Non-dialysis Chronic Kidney Disease Patients
Source: ClinicalTrials.gov · Last updated 24 Feb 2026
Brief summary (registry, in English)
Brief summary template The goal of this clinical trial is to assess endothelial dysfunction in geriatric non-dialysis CKD patients. The main questions it aims to answer are: • In geriatric non-dialysis CKD patients, the study aimed to demonstrate the relationship between soluble vascular endothelial cadherin and fibroblast growth factor-23 levels, which are indicators of endothelial dysfunction-and therefore a possible cardiovascular risk factor-using measurement methods such as ultrasonographic carotid intima-media thickness, flow-mediated dilation, and nailfold capillaroscopy. Participants will have measurement of; * ultrasonographic carotid intima-media thickness, * flow-mediated dilation, * nailfold capillaroscopy * venous blood sampling * Visit the clinic once,
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 101 (actual)
- First submitted
- 12 Feb 2026
- Start date
- 12 May 2023
- Primary completion date
- 11 Sept 2023
- Lead sponsor
- Muğla Sıtkı Koçman University
- Diseases
- Chronic kidney disease
- NCT number
- NCT07430982
What you commit to
- Study type: Interventional
- Participants enrolled: 101
- From 12 May 2023 to the primary completion date, 11 Sept 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- renal transplant patients
Other illness
- history of coronary artery disease
- history of peripheral artery disease
- heart failure
- active infection
- history of active malignancy
- history of cerebrovascular event (ischemic/hemorrhagic)
Age
- Patients under 65 years of age
Other
- atrial fibrillation
- active immunosuppressive use
- Raynaud's phenomenon
Who the study is looking for
- Patients diagnosed with CKD who are not receiving RRT and those aged 65 and over
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mugla Sitki Kocman University Coordinator of this site? Confirm its status | Muğla | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.